Cramer’s lightning round: I like ABM Industries

Cramer’s lightning round: I like ABM Industries


Dow Inc: “I want you to hold on. … Keep it at a 5% yield, buy some more if it goes 5.5%.”

ABM Industries Inc: “Talk about a boring facilities management company that I like so much. You’ve got a real winner there.”

Lockheed Martin Corp: “People are worried about the Republicans and defense budget. I’m worried about the Ukrainians and defending them, and I think Lockheed Martin plays a key role.”

Dynavax Technologies Corp: “As long as you understand that this is a speculative stock and you could lose some money in it, it’s fine by me.”

MPLX LP: “I like the company. I like the cash flows. I like the pipelines.”

Enphase Energy Inc: “I think Enphase Energy is the perfect way to be able to play the Inflation Reduction Act.”

Cramer's lightning round: I like ABM Industries

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.



Source

Nike cuts 1,400 roles in second round of layoffs this year
Business

Nike cuts 1,400 roles in second round of layoffs this year

People walk past a Nike store in New York City, on April 2, 2025. Kylie Cooper | Reuters Nike announced a new round of layoffs on Thursday impacting approximately 1,400 roles across the organization, mostly concentrated in its technology department. In a note from COO Venkatesh Alagirisamy, the company said the layoffs were part of […]

Read More
Trump administration moves to reclassify cannabis in major shift that could expand research
Business

Trump administration moves to reclassify cannabis in major shift that could expand research

The Trump administration moved Thursday to reclassify cannabis under federal law, which could significantly expand scientific research into the drug’s medical uses. The change would not legalize the drug at the federal level, but shift cannabis from its current status as a Schedule I substance to Schedule III under the U.S. Drug Enforcement Administration’s controlled […]

Read More
Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free
Business

Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free

U.S. President Donald Trump (C) speaks during an event on advancing health care affordability in the Oval Office of the White House on April 23, 2026 in Washington, DC. Alex Wong | Getty Images Regeneron agreed to lower U.S. drug prices for some Americans as part of a deal with President Donald Trump, the White […]

Read More